Middle East & Africa Cell Therapy Raw Materials Market Size & Outlook

The cell therapy raw materials market in Middle East & Africa is expected to reach a projected revenue of US$ 245.7 million by 2033. A compound annual growth rate of 17.9% is expected of Middle East & Africa cell therapy raw materials market from 2026 to 2033.
Revenue, 2025 (US$M)
$66.3
Forecast, 2033 (US$M)
$245.7
CAGR, 2026 - 2033
17.9%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa cell therapy raw materials market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA cell therapy raw materials market highlights

  • The MEA cell therapy raw materials market generated a revenue of USD 66.3 million in 2025.
  • The market is expected to grow at a CAGR of 17.9% from 2026 to 2033.
  • In terms of segment, cell culture supplements was the largest revenue generating products in 2025.
  • Media is the most lucrative products segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2026 to 2033.


MEA data book summary

Market revenue in 2025USD 66.3 million
Market revenue in 2033USD 245.7 million
Growth rate17.9% (CAGR from 2026 to 2033)
Largest segmentCell culture supplements
Fastest growing segmentMedia
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationMedia, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Danaher Corp, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Grifols SA Ordinary Shares - Class A, Charles River Laboratories International Inc, Actylis, ACROBiosystems, RoosterBio, PromoCell GmbH


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.2% of the global cell therapy raw materials market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 5,852.2 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell Therapy Raw Materials Market Scope

Cell therapy raw materials market segmentation & scope
Media
Sera
Cell Culture Supplements
Antibodies
Reagents & Buffers
Others
Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Others

Cell Therapy Raw Materials Market Companies

Name Profile # Employees HQ Website
RoosterBio View profile 1-10 Frederick, Maryland, United States, North America http://roosterbio.com
ACROBiosystems View profile 251-500 Newark, Delaware, United States, North America https://www.acrobiosystems.com/
Actylis View profile 501-1000 Port Washington, New York, United States, North America https://actylis.com
PromoCell GmbH View profile 51-100 Heidelberg, Baden-Wurttemberg, Germany, Europe http://www.promocell.com/
Grifols SA Ordinary Shares - Class A View profile 23737 Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 https://www.grifols.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Stemcell Holdings Inc Ordinary Shares View profile - 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 https://www.stemcell-holdings.com
Sartorius AG View profile 14338 Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 https://www.sartorius.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Middle East & Africa cell therapy raw materials market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy raw materials market will help companies and investors design strategic landscapes.


Cell culture supplements was the largest segment with a revenue share of 29.71% in 2025. Horizon Databook has segmented the Middle East & Africa cell therapy raw materials market based on media, sera, cell culture supplements, antibodies, reagents & buffers covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Middle East & Africa cell therapy raw materials market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa cell therapy raw materials market databook

  • Our clientele includes a mix of cell therapy raw materials market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa cell therapy raw materials market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa cell therapy raw materials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA cell therapy raw materials market size, by country, 2021-2033 (US$M)

Middle East & Africa Cell Therapy Raw Materials Market Outlook Share, 2025 & 2033 (US$M)

MEA cell therapy raw materials market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online